Cita APA (7a ed.)
Fu, H., Zhang, J., Pan, T., Ai, S., Tang, L., & Wang, F. (2018). miR-378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c-Raf. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8390
Cita Chicago Style (17a ed.)
Fu, Hongxia, Jicai Zhang, Tongshan Pan, Shuying Ai, Li Tang, y Fengqin Wang. "MiR-378a Enhances the Sensitivity of Liver Cancer to Sorafenib by Targeting VEGFR, PDGFRβ and C-Raf." Molecular Medicine Reports 2018. https://doi.org/10.3892/mmr.2018.8390.
Cita MLA (9a ed.)
Fu, Hongxia, et al. "MiR-378a Enhances the Sensitivity of Liver Cancer to Sorafenib by Targeting VEGFR, PDGFRβ and C-Raf." Molecular Medicine Reports, 2018, https://doi.org/10.3892/mmr.2018.8390.
Precaución: Estas citas no son 100% exactas.